Middle East respiratory syndrome coronavirus in Al-Madinah City, Saudi Arabia: Demographic, clinical and survival data

Journal of Epidemiology and Global Health

Volumn 7, Issue 1, 2017, Pages 29-36

  Sherbini, Nahid ^a   Iskandrani, Ayman ^b   Kharaba, Ayman ^b   Khalid, Ghalilah ^b   Abduljawad, Mohammed ^b   AL Jahdali, Hamdan ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING FAHAD HOSPITAL   (Saudi Arabia)

Author keywords

Characteristics; Coronavirus; Epidemiology; MERS; Saudi Arabia; Survival

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; AZITHROMYCIN; CREATININE; INTERFERON; LEVOFLOXACIN; LINEZOLID; MEROPENEM; PIPERACILLIN; RIBAVIRIN; STEROID;

ADULT; AGE DISTRIBUTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ARTIFICIAL VENTILATION; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; COUGHING; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIARRHEA; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DYSPNEA; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOTENSION; INFECTION RISK; INTENSIVE CARE UNIT; LENGTH OF STAY; LEUKOCYTE COUNT; LUNG GAS EXCHANGE; MALE; MIDDLE AGED; MIDDLE EAST RESPIRATORY SYNDROME; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MORTALITY RATE; RESPIRATORY ACIDOSIS; RETROSPECTIVE STUDY; SAUDI ARABIA; SEX DIFFERENCE; SMOKING; SURVIVAL RATE; THROMBOCYTE COUNT; TREATMENT OUTCOME; VOMITING; CORONAVIRUS INFECTION; DEMOGRAPHY; STATISTICS AND NUMERICAL DATA; SURVIVAL ANALYSIS;

ADULT; COMORBIDITY; CORONAVIRUS INFECTIONS; DEMOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; RETROSPECTIVE STUDIES; SAUDI ARABIA; SURVIVAL ANALYSIS;

EID: 85006379966     PISSN: 22106006     EISSN: 22106014     Source Type: Journal    
DOI: 10.1016/j.jegh.2016.05.002     Document Type: Article

References (26)

1. [1] Zaki, A.M., van Boheemen, S., Bestebroer, T.M., Osterhaus, A.D., Fouchier, R.A., Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367 (2012), 1814–1820.
2. [2] Assiri, A., Al-Tawfiq, J.A., Al-Rabeeah, A.A., Al-Rabiah, F.A., Al-Hajjar, S., Al-Barrak, A., et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis 13 (2013), 752–761.
3. [3] de Groot, R.J., Baker, S.C., Baric, R.S., Brown, C.S., Drosten, C., Enjuanes, L., et al. Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol 87 (2013), 7790–7792.
4. [4] Al-Tawfiq, J.A., Memish, Z.A., Managing MERS-CoV in the healthcare setting. Hosp Pract 43 (2015), 158–163.
5. [5] Ganczak, M., Etiological, epidemiological and clinical aspects of coronavirus infection MERS-CoV. Pol Merkur Lekarski 38 (2015), 46–50 [in Polish].
6. [6] Al-Tawfiq, J.A., Assiri, A., Memish, Z.A., Middle East respiratory syndrome novel corona MERS-CoV infection. Epidemiology and outcome update. Saudi Med J 34 (2013), 991–994.
7. [7] World Health Organization (WHO), Middle East respiratory syndrome coronavirus (MERS-CoV), Summary of current situation, literature update and risk assessment. WHO/MERS/RA/151. Geneva: WHO; 2015.
8. [8] Khan, A., Farooqui, A., Guan, Y., Kelvin, D.J., Lessons to learn from MERS-CoV outbreak in South Korea. J Infect Dev Ctries 9 (2015), 543–546.
9. [9] Park, H.Y., Lee, E.J., Ryu, Y.W., Kim, Y., Kim, H., Lee, H., et al. Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015. Euro Surveill 20 (2015), 1–6.
10. [10] Parry-Ford, F., Boddington, N., Pebody, R., Phin, N., Public health response to two incidents of confirmed MERS-CoV cases travelling on flights through London Heathrow Airport in 2014. Lessons learnt. Euro Surveill 20 (2015), 1–7.
11. [11] Fanoy, E.B., van der Sande, M.A., Kraaij-Dirkzwager, M., Dirksen, K., Jonges, M., van der Hoek, W., et al. Travel-related MERS-CoV cases: an assessment of exposures and risk factors in a group of Dutch travellers returning from the Kingdom of Saudi Arabia, May 2014. Emerg Themes Epidemiol, 11, 2014, 16.
12. [12] EDs on heightened alert for MERS-CoV as first cases reach the US.ED Manag., 26, 2014, 73–77.
13. [13] Kraaij-Dirkzwager, M., Timen, A., Dirksen, K., Gelinck, L., Leyten, E., Groeneveld, P., et al. Middle East respiratory syndrome coronavirus (MERS-CoV) infections in two returning travellers in the Netherlands, May 2014. Euro Surveill, 9, 2014.
14. [14] Omrani, A.S., Shalhoub, S., Middle East respiratory syndrome coronavirus (MERS-CoV): what lessons can we learn?. J Hosp Infect 91 (2015), 188–196.
15. [15] Memish, Z.A., Al-Tawfiq, J.A., Makhdoom, H.Q., Al-Rabeeah, A.A., Assiri, A., Alhakeem, R.F., et al. Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: a prospective descriptive study. Clin Microbiol Infect 20 (2014), 469–474.
16. [16] Assiri, A., McGeer, A., Perl, T.M., Price, C.S., Al Rabeeah, A.A., Cummings, D.A., et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med 369 (2013), 407–416.
17. [17] Memish, Z.A., Cotten, M., Meyer, B., Watson, S.J., Alsahafi, A.J., Al Rabeeah, A.A., et al. Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013. Emerg Infect Dis 20 (2014), 1012–1015.
18. [18] Memish, Z.A., Alsahly, A., Masri, M.A., Heil, G.L., Anderson, B.D., Peiris, M., et al. Sparse evidence of MERS-CoV infection among animal workers living in Southern Saudi Arabia during 2012. Influenza Other Respir Viruses 9 (2015), 64–67.
19. [19] Memish, Z.A., Zumla, A.I., Al-Hakeem, R.F., Al-Rabeeah, A.A., Stephens, G.M., Family cluster of Middle East respiratory syndrome coronavirus infections. N Engl J Med 368 (2013), 2487–2494.
20. [20] Alqurashi, K.A., Aljabri, K.S., Bokhari, S.A., Prevalence of diabetes mellitus in a Saudi community. Ann Saudi Med 31 (2011), 19–23.
21. [21] Hui, D.S., Chan, P.K., Severe acute respiratory syndrome and coronavirus. Infect Dis Clin North Am 24 (2010), 619–638.
22. [22] Drosten, C., Seilmaier, M., Corman, V.M., Hartmann, W., Scheible, G., Sack, S., et al. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis 13 (2013), 745–751.
23. [23] Arabi, Y.M., Arifi, A.A., Balkhy, H.H., Najm, H., Aldawood, A.S., Ghabashi, A., et al. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med 160 (2014), 389–397.
24. [24] Lee, N., Hui, D., Wu, A., Chan, P., Cameron, P., Joynt, G.M., et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 348 (2003), 1986–1994.
25. [25] Fan, C.K., Yieh, K.M., Peng, M.Y., Lin, J.C., Wang, N.C., Chang, F.Y., Clinical and laboratory features in the early stage of severe acute respiratory syndrome. J Microbiol Immunol Infect 39 (2006), 45–53.
26. [26] Ajlan, A.M., Ahyad, R.A., Jamjoom, L.G., Alharthy, A., Madani, T.A., Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings. AJR Am J Roentgenol 203 (2014), 782–787.